DUBLIN, Feb. 26, 2024 /PRNewswire/ — The “Global Venous Thromboembolism Treatment Market by Device (Thrombectomy, Inferior Vena Cava Filter [Retrievable, Permanent], Stockings, Compression Pump) Application (DVT, Pulmonary Embolism) End User (Hospital, Ambulatory Care Center) – Forecast to 2030” report has been added to ResearchAndMarkets.com’s offering.
The latest research report sheds light on the dynamics of the global venous thromboembolism treatment market, projecting significant growth with a compound annual growth rate (CAGR) of 7.2% from 2023 to 2030. The anticipated expansion of the market, which is forecasted to attain a valuation of $4.40 billion by 2030, is being attributed to various factors, including technological advancements and an increasing prevalence of related health conditions.
The comprehensive study, which includes insights from both primary and secondary research, delves into the current challenges and drivers influencing the market. An upsurge in venous thromboembolism occurrences, rising incidences of chronic diseases such as cancer, and heightened instances of risk factors like diabetes and obesity are propelling the market forward. Additionally, the growth is supported by an increase in orthopedic surgeries and the escalating demand for minimally invasive treatment methodologies.
Despite the positive outlook, the market faces certain restraints, including product recalls and a general lack of awareness about venous thromboembolism. Nevertheless, the increased availability and affordability of treatments are expected to offer ample opportunities for market expansion, particularly in emerging economies.
Segmentation Insights
Within the market, the thrombectomy devices segment is poised to dominate in 2023 due to the surging rates of cardiovascular diseases and a preference shift towards minimally invasive procedures. The deep vein thrombosis application is also projected to hold a substantial market share, fueled by lifestyle-related health concerns and a burgeoning geriatric populace.
Hospitals, as end-users, are anticipated to occupy the largest market share in 2023, with factors such as advanced professional expertise, higher purchasing capacities, and comprehensive healthcare offerings playing a crucial role.
Geographical Overview
Geographical analysis shows that in 2023, North America is poised to lead the global market, followed by Europe and Asia-Pacific. The Asia-Pacific region, however, is forecasted to experience the highest CAGR during the forecast period, propelled by growing health infrastructure investments and rising awareness regarding venous thromboembolism treatments.
The market assessment covers various devices, applications, end-users, and key regions, providing an in-depth insight into the complexity and multifaceted nature of the venous thromboembolism treatment sector.
Market Insights
Drivers
High Prevalence of Venous Thromboembolism
Rising Incidence of Cancer
Restraints
Instances of Product Failure and Product Recalls
Opportunities
Growing Accessibility and Affordability of Treatment Options
Advancements in VTE Diagnosis and Treatment Methods
Challenges
Lack of Awareness About Venous Thromboembolism
Competition Analysis
Key Growth Strategies
Competitive Benchmarking
Competitive Dashboard
Industry Leaders
Market Differentiators
Vanguards
Emerging Companies
Market Share Analysis (2022)
Boston Scientific Corporation (U.S.)
Stryker Corporation (U.S.)
Cardinal Health, Inc. (U.S.)
Enovis Corporation (U.S.)
Medtronic plc (Ireland)
Cook Group Incorporated (U.S.)
Company Profiles
ALN Implants chirurgicaux (ALN Surgical Implants)
AngioDynamics, Inc.
Argon Medical Devices, Inc.
ArjoHuntleigh AB
Boston Scientific Corporation
Cardinal Health, Inc.
Cook Group Incorporated
Koninklijke Philips N.V.
DS MAREF Co., Ltd
Enovis Corporation
LifeTech Scientific Corporation
Medtronic plc
Stryker Corporation
Scope of the Report:
Venous Thromboembolism Treatment Market Assessment – by Device
Thrombectomy Devices
Inferior Vena Cava Filters
Retrievable Filters
Permanent Filters
Stockings
Compression Pumps
Other Devices & Accessories
Venous Thromboembolism Treatment Market Assessment – by Application
Deep Vein Thrombosis
Pulmonary Embolism
Venous Thromboembolism Treatment Market Assessment – by End User
Hospitals
Ambulatory Care Centers
Other End Users
Venous Thromboembolism Treatment Market Assessment – by Geography
North America
U.S.
Canada
Europe
Germany
U.K.
France
Italy
Spain
Rest of Europe (RoE)
Asia-Pacific (APAC)
China
Japan
India
Rest of APAC (RoAPAC)
Latin America
Middle East & Africa
For more information about this report visit https://www.researchandmarkets.com/r/xql7x5
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
SOURCE Research and Markets
